DK1023059T3 - Farmaceutiske præparater - Google Patents

Farmaceutiske præparater

Info

Publication number
DK1023059T3
DK1023059T3 DK98961013T DK98961013T DK1023059T3 DK 1023059 T3 DK1023059 T3 DK 1023059T3 DK 98961013 T DK98961013 T DK 98961013T DK 98961013 T DK98961013 T DK 98961013T DK 1023059 T3 DK1023059 T3 DK 1023059T3
Authority
DK
Denmark
Prior art keywords
pentaerythritol
pharmaceuticals
dinatrate
pentaerythrito
petn
Prior art date
Application number
DK98961013T
Other languages
English (en)
Inventor
Ulrich Guenther
Sabine Freitag
Ulrike Kuntze
Wilhelm Thomas Lehr
Original Assignee
Alpharma Isis Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpharma Isis Gmbh & Co Kg filed Critical Alpharma Isis Gmbh & Co Kg
Application granted granted Critical
Publication of DK1023059T3 publication Critical patent/DK1023059T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98961013T 1997-10-16 1998-10-16 Farmaceutiske præparater DK1023059T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19745618 1997-10-16

Publications (1)

Publication Number Publication Date
DK1023059T3 true DK1023059T3 (da) 2006-04-24

Family

ID=7845649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98961013T DK1023059T3 (da) 1997-10-16 1998-10-16 Farmaceutiske præparater

Country Status (12)

Country Link
EP (1) EP1023059B1 (da)
AT (1) ATE313323T1 (da)
AU (1) AU1660399A (da)
CZ (1) CZ301265B6 (da)
DE (3) DE19847781A1 (da)
DK (1) DK1023059T3 (da)
ES (1) ES2255193T3 (da)
HU (1) HUP0100634A3 (da)
PL (1) PL340386A1 (da)
SK (1) SK284769B6 (da)
WO (1) WO1999018930A2 (da)
ZA (1) ZA989356B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1087926A2 (de) * 1998-06-24 2001-04-04 Alpharma-Isis GmbH & Co. KG Analytische substrate und antioxidative mittel
DE102008050597A1 (de) 2008-10-09 2010-04-15 Actavis Deutschland Gmbh & Co. Kg Pharmazeutische Zubereitungen zur Anwendung in einem Verfahren zur therapeutischen Behandlung von Hörsturz

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028307A (en) * 1959-05-27 1962-04-03 Warner Lambert Pharmaceutical Pre-dried granulation and production of sublingual compressed organic nitrate tablets with selected solubilizing agents
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
EP0104877B1 (en) * 1982-09-29 1990-01-17 Ici Americas Inc. Organic nitrate drug mixtures resistant to detonation by fire
DE3328094A1 (de) * 1983-08-04 1985-02-21 H. Trommsdorff GmbH & Co, 5110 Alsdorf Phlegmatisierte pharmazeutische zubereitung von explosionsfaehigen salpetersaeureestern
JP2957618B2 (ja) * 1989-02-20 1999-10-06 バリガドゥー，ソーリアナレン アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物
US5278192A (en) * 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen

Also Published As

Publication number Publication date
EP1023059B1 (de) 2005-12-21
EP1023059A2 (de) 2000-08-02
ES2255193T3 (es) 2006-06-16
DE29880094U1 (de) 2000-05-18
ATE313323T1 (de) 2006-01-15
WO1999018930A3 (de) 1999-10-07
PL340386A1 (en) 2001-01-29
HUP0100634A2 (hu) 2001-07-30
DE19847781A1 (de) 1999-04-22
CZ20001342A3 (cs) 2000-09-13
DE59813300D1 (de) 2006-01-26
SK5382000A3 (en) 2000-11-07
HUP0100634A3 (en) 2003-07-28
CZ301265B6 (cs) 2009-12-23
WO1999018930A2 (de) 1999-04-22
SK284769B6 (sk) 2005-11-03
AU1660399A (en) 1999-05-03
ZA989356B (en) 1998-11-16

Similar Documents

Publication Publication Date Title
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
TR199802423T2 (xx) Konsantre antikor terkibi.
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
DK65293A (da) Fremgangsmåde til administrering af taxol
DE69921138D1 (de) Arzneimittel freisetzendes system enthaltend ein homeobox-peptid und ein zytotoxisches oder antineoplastisches mittel
CA2170255A1 (en) Pharmaceutical Composition for Immunoenhancement Therapy
TW261615B (da)
HUP0001136A2 (hu) Limfatikus tumorok kezelésére szolgáló gyógyszerkészítmények
YU52999A (sh) Kombinacija analgetika
TR199802769T2 (xx) Terpenoid bileşikler ile antihistaminik bileşiklerin bir kombinasyonunu ihtiva eden topikal bileşim.
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
HUP0200055A2 (hu) 16-Hidroxi-ösztratriének és ezeket tartalmazó gyógyszerkészítmények
ATE221391T1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
BG105570A (en) Pharmaceutical compositions for modified release insulin sensitiser
DK0996462T3 (da) Farmaceutiske kombinationspræparater indeholdende erythropoietin og modificerede hæmoglobiner
DK1023059T3 (da) Farmaceutiske præparater
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
AU7028598A (en) Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
BR9714945A (pt) Composição topicamente aplicável para introdução de fármacos peptidaceosos em organismos vivos
AP1692A (en) Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent.
MD1783F1 (en) Method of epilepsy treatment